ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998

Sieber Direct Communications At NCI, Reorganizing Offices.

March 31, 2000

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999